1-3 of 3
Juliana Silva
Close
Sort by
Journal Articles

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Maria Gabelli, Macarena Oporto-Espuelas, Saskia Burridge, Jan Chu, Susan Farish, Emma Hedges, Kirsty Ware, Lindsey Williams, Lindsey Young, Rajesh Alajangi, Philip Ancliff, Jack Bartram, Denise Bonney, Lenka Chenchara, Robert Chiesa, Chiara Cugno, Katharine Hodby, Katarzyna A. Jalowiec, Arina Lazareva, Giovanna Lucchini, Oana C. Mirci-Danicar, Khushnuma Mullanfiroze, Vesna Pavasovic, Anupama Rao, Kanchan Rao, Lynne Riley, Sujith Samarasinghe, Geoff Shenton, Juliana Silva, Ajay Vora, Rachael Hough, Persis J. Amrolia, Sara Ghorashian
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1959–1963.
https://doi.org/10.1182/bloodadvances.2023011168
Published: 2024
Includes: Supplemental data
Journal Articles

CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy

Khushnuma Mullanfiroze, Arina Lazareva, Jan Chu, Lindsey Williams, Saskia Burridge, Juliana Silva, Robert Chiesa, Kanchan Rao, Giovanna Lucchini, Sara Ghorashian, Maeve O’Reilly, Ben Carpenter, Victoria Grandage, Rachael Hough, Claire Roddie, Persis J. Amrolia
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4715–4718.
https://doi.org/10.1182/bloodadvances.2022007572
Published: 2022
Journal Articles

Use of the complement inhibitor Coversin to treat HSCT-associated TMA

Clinical Trials & Observations
Timothy H. J. Goodship, Fernando Pinto, Wynn H. Weston-Davies, Juliana Silva, Jun-ichi Nishimura, Miles A. Nunn, Ian Mackie, Samuel J. Machin, Liina Palm, Jeremy W. Pryce, Robert Chiesa, Persis Amrolia, Paul Veys
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1254–1258.
https://doi.org/10.1182/bloodadvances.2016002832
Published: 2017
Includes: Supplemental data